The Horseracing Integrity and Safety Authority released a request for proposals for research on the administration of furosemide to Thoroughbred racehorses during the 48-hour period before the start of a race. This research is required as part of HISA's Congressional mandate.
The conclusions of this research will be used to guide HISA's Furosemide Advisory Committee in its recommendations to the HISA Board on next steps regarding the administration of furosemide.
Responses to the RFP are due by Nov. 15, 2023, at 11:59 p.m. ET. Questions about the RFP and the process for submitting a response can be sent to Dr. Jennifer Durenberger at jennifer.durenberger@hisaus.org and/or Sam Reinhardt at samuel.reinhardt@hisaus.org. Final proposals can also be submitted via email to Dr. Durenberger and Mr. Reinhardt once completed.
The RFP can be viewed here.
The post HISA Seeking Proposals For Federally Mandated Furosemide Study appeared first on Horse Racing News | Paulick Report.
